RJA
BIOX icon

Raymond James & Associates’s Bioceres Crop Solutions BIOX Stock Holding History

Raymond James & Associates’s Portfolio BIOX Stock Details BIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-27,567
Closed -$311K – 3842
2023
Q3 		$311K Buy
27,567
+1,300
+5% +$15.6K ﹤0.01% 3196
2023
Q2 		$351K Hold
26,267
– – ﹤0.01% 3146
2023
Q1 		$305K Buy
+26,267
New +$309K ﹤0.01% 3232

Other funds holding BIOX

SP
Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
FSC
Fourth Sail Capital Camana Bay Grand Cayman, Cayman Islands $608M AUM 48.69% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
BAM
Ballast Asset Management Dallas, Texas $225M AUM 38.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Raymond James & Associates's BIOX Position: Q4 2023 in Review

Raymond James & Associates sold out of Bioceres Crop Solutions (BIOX) in Q4 2023, closing a stake of 27,567 shares — an estimated $311K sold.

Raymond James & Associates first reported a position in BIOX in Q1 2023 and held it in 3 quarters. The position peaked at $351K in Q2 2023. 51 funds tracked by Wall St. Rank hold BIOX as of Q4 2023.

  • Raymond James & Associates reported no remaining Bioceres Crop Solutions position as of Q4 2023 after selling out during the quarter.
  • Raymond James & Associates sold 27,567 Bioceres Crop Solutions shares in Q4 2023, an estimated $311K.
  • Raymond James & Associates first reported a position in Bioceres Crop Solutions in Q1 2023 and held it in 3 quarters.
  • Raymond James & Associates's Bioceres Crop Solutions position peaked at $351K in Q2 2023.
  • 51 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q4 2023.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.